Literature DB >> 15811460

Autonomic peripheral neuropathy.

Roy Freeman1.   

Abstract

The autonomic neuropathies are a group of disorders in which the small, lightly myelinated and unmyelinated autonomic nerve fibres are selectively targeted. Autonomic features, which involve the cardiovascular, gastrointestinal, urogenital, sudomotor, and pupillomotor systems, occur in varying combination in these disorders. Diabetes is the most common cause of autonomic neuropathy in more developed countries. Autonomic neuropathies can also occur as a result of amyloid deposition, after acute infection, as part of a paraneoplastic syndrome, and after exposure to neurotoxins including therapeutic drugs. Certain antibodies (eg, anti-Hu and those directed against neuronal nicotinic acetylcholine receptor) are associated with autonomic signs and symptoms. There are several familial autonomic neuropathies with autosomal dominant, autosomal recessive, or X-linked patterns of inheritance. Autonomic dysfunction can occur in association with specific infections. The availability of sensitive and reproducible measures of autonomic function has improved physicians' ability to diagnose these disorders.

Entities:  

Mesh:

Year:  2005        PMID: 15811460     DOI: 10.1016/S0140-6736(05)74815-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  59 in total

1.  Paraneoplastic pandysautonomia as a manifestation of non-small cell lung cancer.

Authors:  Kayihan Uluc; Muge Kocak; Pinar Kahraman Koytak; Deniz Borucu; Baris Isak; Sevinc Aktan; Onder Us
Journal:  Neurol Sci       Date:  2010-05-08       Impact factor: 3.307

2.  Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.

Authors:  Burton M Wice; Songyan Wang; Dan L Crimmins; Kelly A Diggs-Andrews; Matthew C Althage; Eric L Ford; Hung Tran; Matthew Ohlendorf; Terry A Griest; Qiuling Wang; Simon J Fisher; Jack H Ladenson; Kenneth S Polonsky
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

Review 3.  Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Authors:  Janneke G Hoeijmakers; Catharina G Faber; Giuseppe Lauria; Ingemar S Merkies; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2012-05-29       Impact factor: 42.937

4.  Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction.

Authors:  Tatiane M Murça; Tatiane C S Almeida; Mohan K Raizada; Anderson J Ferreira
Journal:  Exp Physiol       Date:  2012-01-27       Impact factor: 2.969

5.  The symptoms of autonomic dysfunction in HIV-positive Africans.

Authors:  Caterina Compostella; Leonida Compostella; Ruggiero D'Elia
Journal:  Clin Auton Res       Date:  2007-12-15       Impact factor: 4.435

Review 6.  Management of neurogenic orthostatic hypotension in patients with autonomic failure.

Authors:  Christoph Schroeder; Jens Jordan; Horacio Kaufmann
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

7.  Endovascular procedures for the treatment of autonomic dysfunction.

Authors:  Christopher Gibbons; William Cheshire; Alexandru Barboi; Benjamin Levine; Brian Olshansky; Laurence Kinsella; Victoria E Claydon; Craig Crandall; Gregory Fink; Michael Joyner; Vaughan Macefield; Lucy Norcliffe-Kaufmann; Roy Freeman; Satish Raj; Julian Stewart; Paola Sandroni; Horacio Kaufmann; Thomas Chelimsky
Journal:  Clin Auton Res       Date:  2013-11-01       Impact factor: 4.435

8.  The M2-muscarinic receptor inhibits the development of streptozotocin-induced neuropathy in mouse urinary bladder.

Authors:  K J Pak; R S Ostrom; M Matsui; F J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  2010-07-12       Impact factor: 4.030

9.  Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy.

Authors:  Rajiv A Gandhi; Jefferson L B Marques; Dinesh Selvarajah; Celia J Emery; Solomon Tesfaye
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

10.  Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology.

Authors:  Christopher H Gibbons; Roy Freeman; Aristidis Veves
Journal:  Diabetes Care       Date:  2010-08-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.